At Boston Atrial Fibrillation Symposium 2010, Prof. John Camm talked about the two newest antiarrhythmic drugs for atrial fibrillation treatment, dronedarone (Multaq®) and vernakalant. These antiarrhythmic (rhythm control) drugs help to put patients back into normal sinus rhythm, or to keep them in it. See the video: Interview with Professor John Camm at Boston Atrial …
StopAfib.org salutes our friends at the Arrhythmia Alliance and the Atrial Fibrillation Association, including Founder Trudie Lobban and Executive Committee President Professor John Camm, for their Know Your Pulse campaign to raise awareness of atrial fibrillation in order to encourage diagnosis and treatment of it. The Know Your Pulse campaign encourages easy and inexpensive pulse …